CRF Connect Logo

Heart Failure

Clinical Indications and Science Learning Series

Late-Breaking Trials & Science

Advertisement

Heart Failure >
Late-Breaking Trials & Science

Episodes

A Patient With HF and AR: How and When to Treat With TAVR and SAVR
A Patient With HF and AR: How and When to Treat With TAVR and SAVR
17 min.
Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial
Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial
11 min.
A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial
A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial
14 min.
Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial
Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial
11 min.
Lower Extremity Lymphatic Flow Is Associated With Diuretic Response and Weight Change (Decongestion) in Acute Heart Failure
Lower Extremity Lymphatic Flow Is Associated With Diuretic Response and Weight Change (Decongestion) in Acute Heart Failure
12 min.
Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice
Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice
8 min.
Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study
Safety and Efficacy of the preCARDIA System to Mechanically Reduce Cardiac Preload for Acutely Decompensated Heart Failure: The Expanded VENoUS Heart Failure (VENUS-HF) Early Feasibility Study
10 min.
Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial
Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial
11 min.
Cardiac Microcurrent Application for the Reversal of Heart Failure
Cardiac Microcurrent Application for the Reversal of Heart Failure
9 min.
Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF
Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF
14 min.
Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial
Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial
15 min.
Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure
Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure
10 min.
Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring
Changes in Seated Pulmonary Artery Pressure in Response to Titration of Heart Failure Medications During Ambulatory Monitoring
10 min.
Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis
Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis
10 min.
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial
13 min.
Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results
Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results
10 min.
Robotic Surgical Technique for Performing Heart Transplant
Robotic Surgical Technique for Performing Heart Transplant
16 min.
Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF
Evidence Is Getting STRONGer That Rapid GDMT Uptitration After an AHF Event Is Effective Regardless of LVEF
7 min.
Preserving Access: Limiting the Use of Advanced Therapies
Preserving Access: Limiting the Use of Advanced Therapies
8 min.
Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients
Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients
17 min.
Only Select Patients Should Have a PA Pressure Sensor
Only Select Patients Should Have a PA Pressure Sensor
13 min.
All NYHA III Patients Should Have a PA Pressure Sensor
All NYHA III Patients Should Have a PA Pressure Sensor
6 min.
Increasing Reach: Using TeleHealth to Get STRONGer
Increasing Reach: Using TeleHealth to Get STRONGer
9 min.
Increasing Access: Using Team-Based Care to Get STRONG
Increasing Access: Using Team-Based Care to Get STRONG
8 min.